Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.96
Price to sales ratio
229.62

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3018
VREX
Varex Imaging Corporation - Common Stock
10.59 USD-1.94%-0.56%-6.28%+32.38%445.84 M USD
3170
ELMD
Electromed, Inc. Common Stock
44.54 USD-3.01%+0.84%+16.75%+79.74%368.79 M USD
3306
CV
CapsoVision, Inc. - Common Stock
6.35 USD+2.09%+11.99%-11.81%+44.65%317.27 M USD
3327
MASS
908 Devices Inc. - Common Stock
8.16 USD+2.64%+3.16%-5.34%+19.82%308.56 M USD

Frequently asked questions about Perspective Therapeutics, Inc. Common Stock

What is the Perspective Therapeutics, Inc. Common Stock stock price today?

The current price of Perspective Therapeutics, Inc. Common Stock (CATX) is 3.06. Over the past 24 hours, the stock has changed by -1.29%. Follow the CATX chart for real-time price dynamics.

What is the stock ticker of Perspective Therapeutics, Inc. Common Stock?

Perspective Therapeutics, Inc. Common Stock trades under the ticker CATX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Perspective Therapeutics, Inc. Common Stock stock going up?

CATX has changed by -8.11% over the last week, +1.32% over the last month, and -26.97% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Perspective Therapeutics, Inc. Common Stock net income for the last quarter?

Perspective Therapeutics, Inc. Common Stock reported net income of -26.19 M for the last quarter. The previous quarter showed -37.49 M, which means net income changed by +30.14%.

How many employees does Perspective Therapeutics, Inc. Common Stock have?

As of the latest available data, Perspective Therapeutics, Inc. Common Stock has 166 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Perspective Therapeutics, Inc. Common Stock stock?

You can buy Perspective Therapeutics, Inc. Common Stock (CATX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Perspective Therapeutics, Inc. Common Stock stock?

Investing in Perspective Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CATX chart and related analysis on metatrader.com as part of your research.

Perspective Therapeutics, Inc. Common Stock

Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu. The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354.

News